ClinicalTrials.Veeva

Menu

Breather Exerciser Trainer on Diaphragmatic Mobility And Thickness

A

Adly A Adam

Status

Completed

Conditions

Aging Well

Treatments

Other: Breather Exerciser Trainer
Other: Conventional Breathing Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT06308458
P.T.REC/012/003966

Details and patient eligibility

About

The purpose of this study is to the effect of the breather exerciser trainer on diaphragmatic mobility and thickness in elderly.

Full description

Egypt is the most populous country in Middle East, with expected elder population will reach 20.8% in 2050. Almost, old population undergo sarcopenia, and dynapenia including respiratory musculatures that may associated with elevated mortality rate. Such physiological deteriorations have a potential impact on the elders quality of life.

Therefore, regular specific breathing and exercise training may promote healthier life, and permits more mechanical efficient breathing pattern, thus older population could live a hassle-free life. older adults can maintain and improve their lung capacity.

Enrollment

60 patients

Sex

All

Ages

65 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age range 65-75 years old of both genders
  • Oriented elder subjects assessed for cognitive impairment with score greater than 30 on Mini- Mental Scale.
  • Healthy elders with normal pulmonary function test values according to reference values.

Exclusion criteria

  • Using any medications affect muscular strength.
  • Active hemoptysis, untreated pneumothorax, recent esophageal surgeries.
  • Acute or chronic pulmonary diseases, or decompensated heart failure.
  • Acute upper respiratory stenosis 'true vocal fold mass, vocal fold paralysis in adducted position, sub-glottic stenosis' or recent oral, facial or skull trauma or surgeries, also acute sinusitis, epistaxis, hemodynamic instability, tympanic membrane rupture, or acute middle ear pathology 'otitis or labyrinthitis'.
  • Active smokers.
  • Subjects with previous neurological disorders affecting respiratory muscles or any muscular dystrophies.
  • Subjects with previous cervical or thoracic surgeries.
  • Presence of hemodynamic instability 'heart rate more than 150beat per minute, or systolic blood pressure more than 140 mmHg, or diastolic blood pressure more than 90 mmHg'
  • Presence of severe cognitive impairments affects their understanding of any steps of study protocol.
  • Uncooperative individuals during chest ultrasound measurement that require performance of deep inspiration and full expiration.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Study Group (A)
Experimental group
Description:
Experimental (Breather Exerciser Trainer + conventional breathing exercises) Group 30 healthy elders will receive inspiratory muscle training by breather exerciser trainer (Gradual intensity from 2-3 rate of perceived exertion (RPE) up to reach 5-7 RPE, with gradual frequency; 1st week 8 sets of 5 repetitions '1 minute rest', 2nd week be 9 sets, and 3rd week reach 10 sets of 5 repetitions. then from 4-8 weeks 'end of study protocol' will be 10 sets of 6 repetitions with 1 minute rest between sets.), along with conventional breathing exercises (Diaphragmatic breathing, Pursed-up breathing, and Exercise connected with respiration), for 5 sessions per week for eight weeks.
Treatment:
Other: Conventional Breathing Exercise
Other: Breather Exerciser Trainer
Control Group (B)
Other group
Description:
Control (conventional breathing exercises) Group: 30 health elders will receive conventional breathing exercises (Diaphragmatic breathing; Pursed-up breathing, Exercise connected with respiration for 5 times a week for a total 8 weeks
Treatment:
Other: Conventional Breathing Exercise

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems